Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
NOVARTIS AG et al v. KAPPOS
Case Number:
1:10-cv-01138
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
November 16, 2012
Novartis Loses Fight With USPTO To Extend 19 Patents
A Washington federal judge on Thursday nixed Novartis AG's bid to extend the life on 19 of its patents, ruling the drugmaker waited too long before challenging the U.S. Patent and Trademark Office's patent term adjustment calculations.
-
June 19, 2012
USPTO Says Novartis' Patent Term Case Is Time-Barred
The U.S. Patent and Trademark Office on Monday asked a Washington federal court to block Novartis AG's bid to extend patent term adjustments the drugmaker claims unfairly cut short 23 patents, arguing Novartis' lawsuit is time-barred.
-
July 07, 2010
Novartis Challenges USPTO Patent Extension Policy
Novartis AG has filed suit against the U.S. Patent and Trademark Office, claiming that the agency’s interim method for recalculating patent term adjustments in light of Wyeth v. Kappos has effectively cut short 11 of the drugmaker's patents.